Richard Black is a primary care provider, practicing in Internal Medicine in Quincy, Massachusetts. Dr. Black is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Enlarged Prostate (BPH), Chronic Kidney Disease, Non-Alcoholic Fatty Liver Disease, and Visceromegaly.

John Looney is a primary care provider, practicing in Internal Medicine in Milton, Massachusetts. Dr. Looney is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Low Sodium Level, Urinary Tract Infection in Children, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Ureteroscopy.

Min Song is a primary care provider, practicing in Family Medicine in Milton, Massachusetts. Dr. Song is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Deep Vein Thrombosis, Hypothyroidism, Dementia, and Decerebrate Posture.

Virginia Cummings is an Internal Medicine provider in Milton, Massachusetts. Dr. Cummings is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. Her top areas of expertise are Dehydration, Dementia, Painful Swallowing, and Swallowing Difficulty.

Evgenia Forman is an Internal Medicine provider in Milton, Massachusetts. Dr. Forman is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. Her top areas of expertise are Dysgraphia, Swallowing Difficulty, Painful Swallowing, and Decerebrate Posture.

Cynthia Cullinane is a primary care provider, practicing in Internal Medicine in Quincy, Massachusetts. Dr. Cullinane is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. Her top areas of expertise are Multiple Myeloma, High Cholesterol, Type 2 Diabetes (T2D), and Hypertension.

Mohamed Elgeziry is a primary care provider, practicing in Internal Medicine in Braintree, Massachusetts. Dr. Elgeziry is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Anemia, and Charles Bonnet Syndrome.

Stephen D. Wiviott, MD, FACC is a graduate of University of Pennsylvania and Harvard Medical School (HMS, Honors). He served as a Medicine resident and Chief Medical Resident at Brigham and Women’s Hospital (BWH). Following his medical residency training, he served as a Cardiology fellow at Johns Hopkins Hospital. He is Associate Professor of Medicine at Harvard Medical School, and a Senior Investigator with the TIMI study group. He attends in the Levine Cardiovascular Intensive Care Unit and general Cardiology service at Brigham and Women's Hospital.As an investigator, Dr. Wiviott has played important roles in the planning, implementation, leadership, and interpretation of multicenter, national, and international clinical trials in acute coronary syndromes including the TRITON-TIMI 38 trial, PRINCIPLE-TIMI 44 and of the TIMI 38 Coronary Stent Registry. He has also served in leadership of trials of secondary prevention of cardiovascular disease as global PI of DECLARE – TIMI 58, CAMELLIA – TIMI 61, and DAPA ACT HF – TIMI 68 assessing CV safety and efficacy of metabolic therapies.  He is the Chairman of the TIMI Clinical Events Committee and recognized as an expert in event definitions and adjudications.  Dr. Wiviott is an author of over 200 peer-reviewed publications in major medical and cardiovascular journals including 15 original articles in the New England Journal of Medicine. He was named in 2014 and 2017 by Thomson Reuters and Clarivate Analytics as one of “The World’s Most Influential Scientific Minds” and in 2016-2020 as a “Highly Cited Researcher,” recognitions inclusive of the top 1% of researchers in Clinical Medicine by citation.  Building on his trials experience, Dr. Wiviott serves as Vice President for Clinical Trials Research and Administration for Mass General Brigham and leads the Mass General Brigham Clinical Trials Office.  The CTO provides contracting, budgeting, and clinical trial management services for Mass General Brigham hospital investigators and industry sponsors and is tasked with supporting and growing clinical trials research at Mass General Brigham. Dr. Wiviott is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Attack, Acute Coronary Syndrome, Atrial Fibrillation, Percutaneous Coronary Intervention (PCI), and Angioplasty.

Dominick Kistler is a primary care provider, practicing in Family Medicine in Milton, Massachusetts. Dr. Kistler is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Atypical Pneumonia, Hospital-Acquired Pneumonia, Pneumonia, Ureteroscopy, and Endoscopy.

Saima Khan is a primary care provider, practicing in Internal Medicine in Quincy, Massachusetts. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. Her top areas of expertise are Schnitzler Syndrome, Sitosterolemia, High Cholesterol, and Non-Alcoholic Fatty Liver Disease.

Jennifer Brinckerhoff is an Internal Medicine provider in Roslindale, Massachusetts. Dr. Brinckerhoff is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. Her top areas of expertise are Lewy Body Dementia (LBD), Seasonal Affective Disorder (SAD), Gerstmann Syndrome, and Hypertension.

Dr. Marc Alan Pfeffer is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and the Victor J. Dzau professor of medicine at Harvard Medical School.Dr. Pfeffer received his medical degree from University of Oklahoma College of Medicine. He completed an internal medicine residency and a cardiology fellowship at Peter Bent Brigham Hospital (now BWH). Dr. Pfeffer is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology.Dr. Pfeffer - along with Dr. Janice Pfeffer and Dr. Eugene Braunwald - is credited with introducing the concept that angiotensin-converting enzyme inhibitors (ACEIs) could mitigate adverse ventricular remodeling following myocardial infarction and that ACEI use would result in increased survival and other clinical benefits.His clinical interests include cardiovascular disease, congestive heart failure, coronary artery disease and valvular heart disease. The author of over 450 peer-reviewed publications, he has received research funding from the American Heart Association and National Institutes of Health. Dr. Pfeffer has been listed as one of America’s Top Doctors by Castle Connolly and named a top cardiologist by Boston Magazine. Dr. Pfeffer is the recipient of the Clinical Research Prize and the James Herrick Award, both from the American Heart Association. Dr. Pfeffer is rated as an Advanced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Heart Attack, Acute Coronary Syndrome, and Pacemaker Implantation.

Scott Solomon is a Cardiologist in Boston, Massachusetts. Dr. Solomon is rated as a Distinguished provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Atherosclerosis, Heart Bypass Surgery, and Pacemaker Implantation.

Dr. Vaduganathan is a cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School. He received his medical doctorate and a Master of Public Health degree from Northwestern University. He subsequently completed his residency training in Internal Medicine at Massachusetts General Hospital and fellowship training in Cardiovascular Medicine at Brigham and Women’s Hospital. Dr. Vaduganathan is board certified in internal medicine and cardiovascular disease.Dr. Vaduganathan’s clinical interests surround the intersection between diabetes mellitus, obesity, and heart disease. The author of over 250 peer-reviewed publications, his research focuses on drug development and clinical trials of cardiometabolic therapies. Dr. Vaduganathan is rated as an Advanced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Transplant.

Wei Wang is a primary care provider, practicing in Family Medicine in Boston, Massachusetts. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Lymphofollicular Hyperplasia, Urinary Incontinence, Sitosterolemia, and Hypertension. Dr. Wang is currently accepting new patients.

Fadi Ramadan is a primary care provider, practicing in Geriatrics and Internal Medicine in Boston, Massachusetts. Dr. Ramadan is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Alkaptonuria, Chronic Cough, Vertigo, Type 2 Diabetes (T2D), and Hip Replacement. Dr. Ramadan is currently accepting new patients.

Tomoko Okada is a primary care provider, practicing in Internal Medicine in Jamaica Plain, Massachusetts. Dr. Okada is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. Her top areas of expertise are Gitelman Syndrome, Penile Cancer, Low Potassium Level, and Balanitis.

Gregory Hundemer is a primary care provider, practicing in Internal Medicine in Boston, Massachusetts. Dr. Hundemer is rated as a Distinguished provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Hyperaldosteronism, Hypertension, Low Potassium Level, High Potassium Level, and Kidney Transplant.

Dr. Elazer Reuven Edelman is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and a professor of medicine at Harvard Medical School (HMS).He received his medical degree from HMS and PhD from MIT. He completed an internal medicine residency and a cardiology fellowship at BWH. Dr. Edelman is board certified in internal medicine and cardiovascular disease.Dr. Edelman’s clinical interests include atherosclerotic arterial disease, how this condition is managed and the mechanisms that lead to unstable coronary syndrome.The author of 431 peer-reviewed articles, his research combines his scientific and medical training, using a range of engineering, biological and clinical sciences to examine the cellular and molecular mechanisms of tissue repair. His laboratory helped develop and optimize bare metal and drug-eluting stents, and used device, immune and cell biology to advance studies of endothelial cell and vascular biology. They have pioneered the computational modeling of vessel formation, and emphasized the homology between endothelial paracrine and angiocrine regulation to further delineate the elements of cancer and vascular diseases. Dr. Edelman is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Atherosclerosis, Aortic Valve Stenosis, Cardiogenic Shock, Angioplasty, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Marc S. Sabatine is chairman of the Thrombolysis in Myocardial Infarction (TIMI) Study Group at Brigham and Women’s Hospital (BWH) and holds the Lewis Dexter, MD Distinguished Chair in Cardiovascular Medicine. A cardiovascular specialist, he is also a professor of medicine at Harvard Medical School (HMS).Dr. Sabatine received his medical degree from HMS and completed a residency in internal medicine at Massachusetts General Hospital (MGH). He then completed a clinical fellowship in cardiovascular disease at Massachusetts General Hospital and a fellowship in cardiovascular research at BWH. Dr. Sabatine is board certified in internal medicine and cardiovascular disease and is a fellow of the American Heart Association, the American College of Cardiology and the European Society of Cardiology.His clinical interest is in acute coronary syndromes and critical care, and he attends in the Cardiac Intensive Care Units at both BWH and MGH. His research interests include coronary artery disease, acute coronary syndromes, dyslipidemias, proteomics and genomics. As the chairman of the TIMI Study Group—an academic research organization that has led major cardiovascular medicine clinical trials since its inception in 1984—Dr. Sabatine leads large-scale international randomized controlled trials testing novel therapies for cardiovascular care that have shaped the practice of medicine.Dr. Sabatine has authored over 200 peer-reviewed publications, is on the writing committees for practice guidelines, and has received research funding from the American College of Cardiology and the National Institutes of Health. Dr. Sabatine is rated as an Experienced provider by MediFind in the treatment of Low Potassium Level. His top areas of expertise are Heart Attack, Heart Failure, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).